VV-14299
Asset
AAV vector-mediated delivery of glucokinase to promote glucose uptake
- Stage
- Phase 1
- Modality
- Gene therapy
- Target
- Insulin/IGF-1 signalling
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1Type 1 diabetes
Phase 1, Recruiting, NCT07829302, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains4
- Owner and partners1
- Trials1
- Evidence for its targets4
- Competitors12
- Aging relevance1
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.